Tiffany A Traina Selected Research

Tiffany A Traina Research Topics

Disease

38	Breast Neoplasms (Breast Cancer) 10/2022 - 06/2004
27	Neoplasms (Cancer) 01/2022 - 10/2004
14	Triple Negative Breast Neoplasms 04/2021 - 01/2010
6	Disease Progression 11/2019 - 01/2010
5	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 06/2015
3	Fatigue 10/2022 - 10/2011
2	Neutropenia 10/2022 - 12/2018
2	Nausea 12/2018 - 10/2011
2	Carcinogenesis 07/2013 - 01/2010
1	Mouth Neoplasms (Oral Cancer) 10/2022
1	Exanthema (Rash) 08/2020
1	Peripheral Nervous System Diseases (PNS Diseases) 12/2018
1	Arthralgia (Joint Pain) 12/2018
1	Confusion (Bewilderment) 08/2018
1	Anemia 08/2018
1	Delirium 08/2018
1	Diarrhea 04/2016
1	Hypersensitivity (Allergy) 04/2016
1	Cognitive Dysfunction 06/2014
1	Cough 10/2011
1	Circulating Neoplastic Cells 10/2011
1	Hyponatremia 10/2011
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 10/2011
1	Dyspnea (Shortness of Breath) 10/2011
1	Neoplasm Metastasis (Metastasis) 04/2010
1	Hypertension (High Blood Pressure) 02/2010
1	Headache (Headaches) 02/2010
1	Proteinuria 02/2010
1	Leukemia 02/2010

Drug/Important Bio-Agent (IBA)

12	Hormones (Hormone)IBA 10/2022 - 06/2004
11	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 04/2009
10	Estrogen ReceptorsIBA 01/2022 - 04/2009
6	Progesterone Receptors (Progesterone Receptor)IBA 08/2017 - 04/2009
6	Bevacizumab (Avastin)FDA Link 09/2011 - 11/2006
5	Pharmaceutical PreparationsIBA 04/2021 - 04/2008
5	AndrogensIBA 10/2017 - 07/2013
5	Estrogens (Estrogen)FDA Link 08/2017 - 04/2009
5	Capecitabine (Xeloda)FDA Link 01/2016 - 04/2008
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2010 - 04/2007
3	ErbB Receptors (EGF Receptor)IBA 10/2022 - 12/2018
3	Trastuzumab (Herceptin)FDA Link 11/2019 - 01/2012
3	Paclitaxel (Taxol)FDA LinkGeneric 04/2016 - 04/2009
2	palbociclibIBA 10/2022 - 01/2014
2	PlatinumIBA 01/2021 - 06/2015
2	human ERBB2 proteinIBA 11/2019 - 03/2016
2	seviteronelIBA 08/2018 - 03/2016
2	enzalutamideIBA 01/2018 - 08/2017
2	Lapatinib (GW572016)FDA Link 04/2016 - 01/2012
2	bicalutamide (Casodex)FDA LinkGeneric 03/2016 - 10/2013
2	Biomarkers (Surrogate Marker)IBA 06/2015 - 07/2013
2	Letrozole (Femara)FDA LinkGeneric 01/2014 - 02/2010
2	Aromatase InhibitorsIBA 02/2010 - 06/2004
2	Docetaxel (Taxotere)FDA Link 01/2010 - 04/2009
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 04/2021
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 04/2021
1	B7-H1 AntigenIBA 04/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2020
1	AlpelisibIBA 08/2020
1	Histamine H1 AntagonistsIBA 08/2020
1	Gemcitabine FDA Link 11/2019
1	pertuzumabIBA 11/2019
1	Taxoids (Taxanes)IBA 11/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2018
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2018
1	eribulin FDA Link 12/2018
1	pegfilgrastim (Neulasta)FDA Link 12/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2018
1	Mitogen-Activated Protein KinasesIBA 10/2018
1	LyasesIBA 08/2018
1	Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA 08/2018
1	CytochromesIBA 08/2018
1	Anastrozole (Arimidex)FDA LinkGeneric 08/2017
1	Fulvestrant (Faslodex)FDA Link 08/2017
1	exemestane (Aromasin)FDA Link 08/2017
1	Abiraterone AcetateIBA 03/2016
1	Progesterone FDA LinkGeneric 03/2016
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2016
1	Albumin-Bound Paclitaxel FDA Link 06/2015
1	tigatuzumabIBA 06/2015
1	Monoclonal AntibodiesIBA 06/2015
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 06/2015
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2012
1	saracatinibIBA 10/2011
1	EnzymesIBA 10/2011
1	Epidermal Growth Factor (EGF)IBA 01/2011
1	SteroidsIBA 01/2010
1	Insulin-Like PeptidesIBA 12/2009
1	Somatomedin Receptors (Somatomedin Receptor)IBA 12/2009
1	ParaffinIBA 08/2009
1	Formaldehyde (Formol)FDA Link 08/2009
1	Eosine Yellowish-(YS) (Eosin)IBA 07/2009
1	Hematoxylin (Haematoxylon)IBA 07/2009

Therapy/Procedure

24	Therapeutics 10/2022 - 06/2004
10	Drug Therapy (Chemotherapy) 04/2021 - 01/2008
2	Lymph Node Excision (Lymph Node Dissection) 04/2010 - 07/2009
1	Castration 08/2018
1	Highly Active Antiretroviral Therapy (HAART) 07/2014
1	Time-to-Treatment 10/2011
1	Adjuvant Chemotherapy 07/2009